Novo Nordisk Joins Fight With HHS Over Drug Price Talks

By Theresa Schliep · October 2, 2023, 9:55 PM EDT

Novo Nordisk Inc. joined other Big Pharma companies on Friday suing over the Inflation Reduction Act's Medicare drug price negotiation provision, calling the program "extreme and unprecedented" in a lawsuit filed...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

NOVO NORDISK INC. et al v. BECERRA et al

Case Number

3:23-cv-20814

Court

New Jersey

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

September 29, 2023

Recent Articles By Theresa

July 23, 2024
Kickback Risk Remains For Gene Therapy Fertility Programs
July 16, 2024
No Let-Up On DOJ Medicare Advantage Fraud Probes
July 09, 2024
Jarkesy Decision May Hit Key Healthcare Enforcement Tool
July 02, 2024
4 Takeaways From FDA's Clinical Trial Diversity Guidance
June 28, 2024
Health Regulators Likely To Tread Carefully Post-Chevron
June 25, 2024
Mich. Judge Blocks State Abortion Waiting Period, Counseling
June 25, 2024
In High Court Loss, Anti-Abortion Atty Sees Win For Objectors
June 18, 2024
Prelogar's Mifepristone Win Is 'A Master Class,' Advocates Say
June 13, 2024
Abortion Medication Case Ends 'With A Whimper' At High Court
June 04, 2024
HHS Guidance, Feud Over FCA Evidence, And A Deposed AG